Cart
sales@molnova.com
Brilliant blue G-250
CAS No. 6104-58-1
Brilliant blue G-250( Brilliant Blue G | BBG | Acid blue 90, Coomassie Brilliant Blue G )
Catalog No. M27320 CAS No. 6104-58-1
Brilliant Blue G is an antagonist of the P2X7 purinergic receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 36 | In Stock |
|
| 100MG | 50 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 119 | In Stock |
|
| 1G | 176 | In Stock |
|
Biological Information
-
Product NameBrilliant blue G-250
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrilliant Blue G is an antagonist of the P2X7 purinergic receptor.
-
DescriptionBrilliant Blue G is an antagonist of the P2X7 purinergic receptor.
-
In Vitro——
-
In Vivo——
-
SynonymsBrilliant Blue G | BBG | Acid blue 90, Coomassie Brilliant Blue G
-
PathwayMembrane Transporter/Ion Channel
-
TargetP2X Receptor
-
RecptorAChE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6104-58-1
-
Formula Weight854.02
-
Molecular FormulaC47H48N3NaO7S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (14.64 mM)
-
SMILES[Na+].CCOc1ccc(Nc2ccc(cc2)C(=C2\C=C/C(/C=C2C)=[N+](\CC)Cc2cccc(c2)S([O-])(=O)=O)\c2ccc(cc2C)N(CC)Cc2cccc(c2)S([O-])(=O)=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cardoso-Lopes EM, et al. Alkaloids from stems of Esenbeckia leiocarpa Engl. (Rutaceae) as potential treatment for Alzheimer disease. Molecules. 2010 Dec 13;15(12):9205-13.
molnova catalog
related products
-
Camlipixant
Camlipixant (BLU-5937) is an orally active purine P2X3 receptor antagonist that is potent, selective and competitive.
-
Minodronic acid
Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis.
-
JNJ-54175446
JNJ-54175446 (JNJ-5446) is a CNS-permeable and selective P2X7 receptor antagonist that attenuates the release of IL-1β/IL-18 from microglia, and may be used in the study of depression.
